The Wolverine Stack — BPC-157 10mg / TB-500 10mg
Performance & Recovery
Overview
The Wolverine Stack combines BPC-157 and TB-500, two synthetic peptides studied within research environments for their interaction with cellular and regulatory pathways.
Classification: Two-peptide research stack: BPC-157 (a 15 amino-acid partial sequence of the human gastric juice protein BPC) and TB-500 (a synthetic fragment of thymosin β-4).
Research background
Within laboratory settings, BPC-157 and TB-500 are studied for their interaction with cellular and regulatory pathways. Research applications focus on peptide stability, receptor binding activity, and signalling pathway modelling under controlled experimental conditions.
This summary describes published preclinical and, where applicable, clinical research. It is not a medical claim and does not describe or endorse any human use of the compound as sold by Peptides UK 4U.
Mechanism of action (under investigation)
BPC-157 is investigated in preclinical literature for angiogenic and endothelial-signalling activity, including effects on vascular and gastrointestinal healing markers in rodent models. TB-500 (thymosin β-4-derived) is studied for actin-sequestering activity and effects on cell migration in wound-model research. Combined pharmacology is not characterised — refer to single-agent literature.
Laboratory handling
This product is typically reconstituted using bacteriostatic water or a suitable sterile solvent within a controlled laboratory setting. All handling should be carried out by qualified professionals using appropriate sterile techniques and safety procedures.
Storage & stability
- Store in a cool, dry environment before reconstitution.
- For extended stability, storage at -20°C is recommended.
- Avoid repeated freeze-thaw cycles after reconstitution.
For reconstitution volumes and target working concentrations use our peptide calculator. We do not publish dosing protocols for human use.
Product specifications
- Stack
- The Wolverine Stack
- Peptides
- BPC-157 / TB-500
- Form
- Lyophilised powder
- Quantity
- 10mg per peptide
- Purity
- ≥98% (subject to batch testing)
- Appearance
- White lyophilised powder
- Solubility
- Water soluble
- Stability
- Maintains integrity under controlled storage conditions
- Manufacturing Standard
- Produced in controlled laboratory environments
Certificate of Analysis: Available on request from our support team.
Frequently asked questions
What is The Wolverine Stack?
The Wolverine Stack pairs two of the most widely studied recovery-research peptides — BPC-157 (10mg) and TB-500 (10mg) — supplied as separate lyophilised vials for parallel in vitro investigation.
Why are BPC-157 and TB-500 studied together?
BPC-157 (a 15-residue fragment from gastric juice) and TB-500 (a synthetic Thymosin-β4 fragment) act on different pathways associated with tissue-repair and cellular-signalling research, so they are frequently combined in comparator protocols.
What purity are the vials?
Both vials are tested to ≥98% purity by RP-HPLC. Batch-specific Certificates of Analysis are available on request.
How are the vials reconstituted?
Each 10mg vial is reconstituted independently with bacteriostatic water in a sterile laboratory environment — see our peptide calculator for target concentrations. Prepare working aliquots to minimise freeze-thaw cycles.
References
- Sikirić P et al., Current Pharmaceutical Design 20(7):1126–1135 (2014) — BPC-157
- Goldstein AL et al., Annals of the NY Academy of Sciences 1112:1–14 (2007) — thymosin β4
- Xing Y et al., Peptides 101:9–15 (2018) — thymosin β4 fragment research
References are provided for educational context. Citation does not imply endorsement of any specific use.
Disclaimer: This article is provided for laboratory and educational purposes only. It is not medical advice and does not describe or endorse any human use. All products sold by Peptides UK 4U are for laboratory research only, are not for human or veterinary consumption, and are not intended to diagnose, treat, cure or prevent any disease.